Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of worldwide rights (except for Japan and the US) for Bondronat® and Bonviva® from F. Hoffmann-La Roche Limited (“Roche”). Bonviva® and Bondronat® are injectable and tablet forms of ibandronic acid used for the treatment of osteoporosis and metastatic bone disease respectively. It is Atnahs’ fourth product acquisition from Roche, following Naprosyn®/ Anaprox® and Toradol® in 2015, and Kytril® earlier this year. Amit Patel, Atnahs’ Managing Director, comments, “The acquisition of Bonviva® and Bondronat® expands our global presence to over 130 territories worldwide and enhances our presence in...
Read more
Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of Kytril® from F.Hoffmann-La Roche Limited (“Roche”). Kytril® (granisetron hydrochloride) is an injectable and oral treatment for nausea and vomiting caused by other medical treatments, such as chemotherapy or radiotherapy. It is the third acquisition by Atnahs from Roche following Naprosyn®/ Anaprox® and Toradol® in 2015. Amit Patel, Atnahs’ Managing Director, comments, “The acquisition of Kytril® expands our global presence to over 100 territories worldwide and give us a significant presence in the Middle East and Latin America in particular. Following this acquisition, we will have an...
Read more
Nuffield Health, the UK’s largest independent not-for-profit healthcare organisation, today expanded into virtual general practice through a partnership with Doctor Care Anywhere, a leading online primary care provider. The partnership will allow Nuffield Health’s corporate clients to offer their employees 20 minute virtual GP appointments, seven days a week, 365 days a year, whether in the UK or abroad. The appointments can be accessed via a smartphone app, website or telephone from 8am to 10pm with the option to extend consultations beyond 20 minutes based on individual case needs. The service is to be expanded to a 24 hour operation...
Read more
Sovereign Property is pleased to announce the recent purchase of a site in Lund, Southern Sweden totalling nearly 200,000 sq.m., which is predominantly let to long-standing tenants including A&R Packaging, Thomas Cook and Axis. With the new railway station to be built alongside and the recent decision to move a water treatment plant to the rear, Sovereign Property believes that the site offers excellent opportunities either to retain in its existing use or consider alternative residential-led schemes. Sovereign Property is hopefully the first of many international purchases and it would be delighted to discuss other similar value-add opportunities. Please contact...
Read more
Waymade Capital forms part of a consortium led by Duke Street, the mid-market private equity firm, to acquire Medi-Globe Corp, a German medical devices business focussed on minimally invasive surgery in gastroenterology and urology. Headquartered in Achenmühle, Germany, Medi-Globe is a developer, manufacturer and distributor of disposable accessories for use in flexible endoscopy in the fields of gastroenterology and urology. In addition, the Group is a distributor of a wide range of hospital supplies to an expanding range of customers. Its main markets are in Germany and France, with developing businesses elsewhere in Europe, China, Japan and Brazil. Medi-Globe, a...
Read more
Synergix continues to expand its digital health portfolio to bolster its leading clinical and digital capabilities The company has acquired Prosper, a London-based digital design agency for health and productivity founded by Stuart Wakeford and Dan Bladon. Within the last year Prosper launched highly acclaimed long-term condition app Health Mapper. Health Mapper is an iOS app to help millions of people with long-term conditions better manage their health and get more out of their appointments with clinicians. It allows users to track any health condition (or multiple conditions) and its associated symptoms, medication and measurements. The app provides a diary for...
Read more
Read about our philanthropic endeavours at The Shanta Foundation.